Covalon Technologies Ltd. is a Canadian medical device company specializing in the research, development, manufacturing, and commercialization of advanced medical technologies. Their core focus areas include innovative solutions for wound care (e.g., CovaWound™), infection prevention (e.g., IV Clear®), and specialized medical device coatings. Covalon aims to improve patient outcomes, reduce healthcare-associated infections, and provide safer, more effective medical products to healthcare providers and patients globally. Their patented technologies are used in hospitals, clinics, and other healthcare settings.
The headquarters serves as the primary center for corporate management, research and development, product innovation, manufacturing oversight, and strategic global operations.
The facility likely includes modern office spaces, research laboratories equipped for medical technology development, and potentially clean room environments for certain manufacturing processes.
The work culture at Covalon's HQ emphasizes innovation, collaboration, scientific rigor, and a commitment to improving patient care. Employees often work in cross-functional teams to bring new medical technologies from concept to market.
Located within the Greater Toronto Area, a significant hub for life sciences and medical technology in Canada, the headquarters benefits from access to skilled talent, research institutions, and a supportive business ecosystem.
Covalon Technologies Ltd. has a global reach, with its primary operations centered in Canada (Headquarters, R&D, Manufacturing oversight) and the United States (Sales, Marketing, Distribution). Beyond these direct presences, Covalon's products are marketed and sold internationally through a network of distribution partners in various regions, including Europe, the Middle East, Latin America, and Asia-Pacific. Global functions supported include international sales management, regulatory compliance for different markets, and logistics for product distribution worldwide.
2500 Argentia Road, Unit 15
Mississauga
Ontario
Canada
Address: Covalon Technologies Inc. (USA), 400 Crossing Blvd, 4th Floor, Bridgewater, NJ 08807, USA
To directly engage with U.S. healthcare providers, manage distribution channels, and navigate the regulatory landscape within the United States, ensuring Covalon's products reach American patients and clinicians effectively.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Covalon Technologies Ltd.' leadership includes:
Covalon Technologies Ltd. has been backed by several prominent investors over the years, including:
Covalon Technologies Ltd. confirmed a key permanent appointment in its finance leadership in the last 12 months. Other notable leadership appointments occurred slightly prior to this period, strengthening the commercial and operational teams.
Discover the tools Covalon Technologies Ltd. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Covalon Technologies Ltd. likely uses common corporate email formats. The most probable format combines the first initial and last name, or the full first name and last name.
[first_initial][last]@covalon.com
Format
jdoe@covalon.com
Example
80%
Success rate
Accesswire (via Covalon) • March 28, 2024
Covalon Technologies Ltd. announced the results of its annual and special meeting of shareholders, where all proposed resolutions were passed, including the election of directors and the appointment of auditors....more
Accesswire (via Covalon) • February 29, 2024
Covalon reported its financial results for the first quarter of fiscal year 2024, ended December 31, 2023, detailing revenue figures, gross margins, and operational updates....more
Covalon Press Release (in Q4/Year-End Report) • November 13, 2023
Covalon Technologies Ltd. formally announced the appointment of Jason M. M. Chen as its permanent Chief Financial Officer, effective November 13, 2023. Mr. Chen had been serving as Interim CFO prior to this confirmation....more
Accesswire (via Covalon) • November 2, 2023
Covalon Technologies Ltd. announced the appointment of Mr. Brent Ashton to its Board of Directors, bringing extensive experience in medical device commercialization and capital markets....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Covalon Technologies Ltd., are just a search away.